Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway
Lu Chen, Xingang Sun, Zhen Wang, Miao Chen, Yuxian He, Han Zhang, Deheng Han, Liangrong Zheng
Topics & Concepts
MAPK/ERK pathwayCardiotoxicityPharmacologyp38 mitogen-activated protein kinasesKinaseDoxorubicinResveratrolProgrammed cell deathSignal transductionGlutathioneGPX4ChemistryCancer researchApoptosisCell biologyMedicineToxicityGlutathione peroxidaseBiologyBiochemistryChemotherapyInternal medicineEnzymeOrganic chemistryFerroptosis and cancer prognosisCircular RNAs in diseasesCancer, Lipids, and Metabolism